应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
AVIR Atea Pharmaceuticals, Inc.
未开盘 07-10 16:00:00 EDT
3.78
+0.02
+0.53%
盘后
3.78
+0.00
0.00%
19:33 EDT
最高
3.83
最低
3.75
成交量
32.43万
今开
3.75
昨收
3.76
日振幅
1.99%
总市值
3.23亿
流通市值
2.50亿
总股本
8,558万
成交额
122.82万
换手率
0.49%
流通股本
6,623万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Atea Pharmaceuticals, Inc.盘中异动 股价大涨5.00%
市场透视 · 07-02
Atea Pharmaceuticals, Inc.盘中异动 股价大涨5.00%
Atea Pharmaceuticals, Inc.盘中异动 临近午盘股价大涨5.65%报3.65美元
市场透视 · 06-30
Atea Pharmaceuticals, Inc.盘中异动 临近午盘股价大涨5.65%报3.65美元
Atea Pharmaceuticals, Inc.盘中异动 快速上涨5.05%报3.12美元
市场透视 · 06-02
Atea Pharmaceuticals, Inc.盘中异动 快速上涨5.05%报3.12美元
Atea Pharmaceuticals, Inc.2025财年第一财季实现净利润-34.27百万美元,同比增加45.75%
市场透视 · 05-18
Atea Pharmaceuticals, Inc.2025财年第一财季实现净利润-34.27百万美元,同比增加45.75%
Atea Pharmaceuticals, Inc.盘中异动 股价大涨5.02%
市场透视 · 05-16
Atea Pharmaceuticals, Inc.盘中异动 股价大涨5.02%
Atea Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.15%报2.86美元
市场透视 · 05-12
Atea Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.15%报2.86美元
Atea Pharmaceuticals, Inc.盘中异动 股价大跌5.07%
市场透视 · 05-06
Atea Pharmaceuticals, Inc.盘中异动 股价大跌5.07%
Atea Pharmaceuticals, Inc.盘中异动 早盘快速拉升5.00%
市场透视 · 04-17
Atea Pharmaceuticals, Inc.盘中异动 早盘快速拉升5.00%
Atea Pharmaceuticals, Inc.盘中异动 大幅拉升5.32%
市场透视 · 04-16
Atea Pharmaceuticals, Inc.盘中异动 大幅拉升5.32%
Atea Pharmaceuticals, Inc.盘中异动 急速拉升5.72%
市场透视 · 04-14
Atea Pharmaceuticals, Inc.盘中异动 急速拉升5.72%
Atea Pharmaceuticals, Inc.2024财年实现净利润-1.68亿美元,同比减少23.53%
市场透视 · 03-09
Atea Pharmaceuticals, Inc.2024财年实现净利润-1.68亿美元,同比减少23.53%
Atea Pharmaceuticals公司第四季度每股亏损0.40美元,未达到预期的每股亏损0.37美元
财报速递 · 03-06
Atea Pharmaceuticals公司第四季度每股亏损0.40美元,未达到预期的每股亏损0.37美元
Atea Pharmaceuticals, Inc.盘中异动 股价大涨5.05%报3.12美元
市场透视 · 02-05
Atea Pharmaceuticals, Inc.盘中异动 股价大涨5.05%报3.12美元
Atea Pharmaceuticals, Inc.盘中异动 大幅拉升5.12%报3.60美元
市场透视 · 01-03
Atea Pharmaceuticals, Inc.盘中异动 大幅拉升5.12%报3.60美元
Atea Pharmaceuticals, Inc.盘中异动 早盘快速上涨5.37%
市场透视 · 01-02
Atea Pharmaceuticals, Inc.盘中异动 早盘快速上涨5.37%
Atea Pharmaceuticals, Inc.盘中异动 股价大涨5.11%
市场透视 · 2024-12-20
Atea Pharmaceuticals, Inc.盘中异动 股价大涨5.11%
Atea Pharmaceuticals, Inc.盘中异动 股价大涨9.22%
市场透视 · 2024-12-16
Atea Pharmaceuticals, Inc.盘中异动 股价大涨9.22%
Atea Pharmaceuticals, Inc.盘中异动 股价大跌5.30%
市场透视 · 2024-12-10
Atea Pharmaceuticals, Inc.盘中异动 股价大跌5.30%
Atea Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.14%报2.96美元
市场透视 · 2024-12-05
Atea Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.14%报2.96美元
Atea Pharmaceuticals, Inc.盘中异动 早盘急速下跌5.17%报3.30美元
市场透视 · 2024-12-04
Atea Pharmaceuticals, Inc.盘中异动 早盘急速下跌5.17%报3.30美元
加载更多
公司概况
公司名称:
Atea Pharmaceuticals, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Atea Pharmaceuticals, Inc.于2012年7月注册成立,并于2014年3月开始主要运营。该公司是一家临床阶段的生物制药公司,利用对抗病毒药物开发、药物化学、生物学、生物化学和病毒学的深刻理解,发现和开发新型口服候选产品,以治疗严重的病毒性疾病。
发行价格:
--
{"stockData":{"symbol":"AVIR","market":"US","secType":"STK","nameCN":"Atea Pharmaceuticals, Inc.","latestPrice":3.78,"timestamp":1752177600000,"preClose":3.76,"halted":0,"volume":324325,"hourTrading":{"tag":"盘后","latestPrice":3.78,"preClose":3.78,"latestTime":"19:33 EDT","volume":5680,"amount":21465.01,"timestamp":1752190407438},"delay":0,"floatShares":66231598,"shares":85579475,"eps":-1.649272,"marketStatus":"未开盘","change":0.02,"latestTime":"07-10 16:00:00 EDT","open":3.75,"high":3.825,"low":3.75,"amount":1228228.958805,"amplitude":0.019947,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.649272,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752220800000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1604030400000,"exchange":"NASDAQ","adjPreClose":3.76,"preHourTrading":{"tag":"盘前","latestPrice":3.76,"preClose":3.76,"latestTime":"09:29 EDT","volume":142,"amount":534.4202092,"timestamp":1752154199999},"postHourTrading":{"tag":"盘后","latestPrice":3.78,"preClose":3.78,"latestTime":"19:33 EDT","volume":5680,"amount":21465.01,"timestamp":1752190407438},"volumeRatio":0.839066,"impliedVol":1.966,"impliedVolPercentile":0.6707},"requestUrl":"/m/hq/s/AVIR","defaultTab":"news","newsList":[{"id":"2548811432","title":"Atea Pharmaceuticals, Inc.盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548811432","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548811432?lang=zh_cn&edition=full","pubTime":"2025-07-03 00:44","pubTimestamp":1751474648,"startTime":"0","endTime":"0","summary":"北京时间2025年07月03日00时44分,Atea Pharmaceuticals, Inc.股票出现波动,股价快速上涨5.00%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.86%。Atea Pharmaceuticals, Inc.公司简介:Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化抗病毒疗法,以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070300440897978172&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070300440897978172&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AVIR"],"gpt_icon":0},{"id":"2548016147","title":"Atea Pharmaceuticals, Inc.盘中异动 临近午盘股价大涨5.65%报3.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548016147","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548016147?lang=zh_cn&edition=full","pubTime":"2025-06-30 23:48","pubTimestamp":1751298508,"startTime":"0","endTime":"0","summary":"北京时间2025年06月30日23时48分,Atea Pharmaceuticals, Inc.股票出现波动,股价大幅上涨5.65%。截至发稿,该股报3.65美元/股,成交量8.125万股,换手率0.09%,振幅3.91%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.40%。Atea Pharmaceuticals, Inc.公司简介:Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化抗病毒疗法,以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630234828a7267af2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630234828a7267af2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AVIR"],"gpt_icon":0},{"id":"2540794225","title":"Atea Pharmaceuticals, Inc.盘中异动 快速上涨5.05%报3.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540794225","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540794225?lang=zh_cn&edition=full","pubTime":"2025-06-02 23:45","pubTimestamp":1748879120,"startTime":"0","endTime":"0","summary":"北京时间2025年06月02日23时45分,Atea Pharmaceuticals, Inc.股票出现波动,股价急速拉升5.05%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为1.67%。Atea Pharmaceuticals, Inc.公司简介:Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化抗病毒疗法,以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602234521976e97ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602234521976e97ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AVIR"],"gpt_icon":0},{"id":"2536122594","title":"Atea Pharmaceuticals, Inc.2025财年第一财季实现净利润-34.27百万美元,同比增加45.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536122594","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536122594?lang=zh_cn&edition=full","pubTime":"2025-05-19 00:00","pubTimestamp":1747584056,"startTime":"0","endTime":"0","summary":"5月19日,Atea Pharmaceuticals, Inc.公布财报,公告显示公司2025财年第一财季净利润为-34.27百万美元,同比增加45.75%;其中营业收入为0.00美元,每股基本收益为-0.40美元。机构评级:截至2025年5月19日,当前有1家机构对Atea Pharmaceuticals, Inc.目标价做出预测,其中目标均价为6.00美元,其中最低目标价为6.00美元,最高目标价为6.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000306a6e3a79c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000306a6e3a79c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVIR"],"gpt_icon":0},{"id":"2535315433","title":"Atea Pharmaceuticals, Inc.盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535315433","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535315433?lang=zh_cn&edition=full","pubTime":"2025-05-16 21:56","pubTimestamp":1747403803,"startTime":"0","endTime":"0","summary":"北京时间2025年05月16日21时56分,Atea Pharmaceuticals, Inc.股票出现波动,股价急速上涨5.02%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.31%。其相关个股中,Affimed N.V.、Inozyme Pharma, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大,Affimed N.V.、Polyrizon Ltd.、Nucana Plc较为活跃,换手率分别为2426.50%、1708.19%、927.97%,振幅较大的相关个股有Affimed N.V.、阿卡迪亚、Vor Biopharma Inc.,振幅分别为466.98%、36.59%、36.51%。Atea Pharmaceuticals, Inc.公司简介:Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化抗病毒疗法,以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516215643a6e1bf42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516215643a6e1bf42&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AVIR"],"gpt_icon":0},{"id":"2534720858","title":"Atea Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.15%报2.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2534720858","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2534720858?lang=zh_cn&edition=full","pubTime":"2025-05-12 22:53","pubTimestamp":1747061599,"startTime":"0","endTime":"0","summary":"北京时间2025年05月12日22时53分,Atea Pharmaceuticals, Inc.股票出现异动,股价大幅上涨5.15%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为2.94%。Atea Pharmaceuticals, Inc.公司简介:Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化抗病毒疗法,以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512225320a6dc63e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250512225320a6dc63e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AVIR"],"gpt_icon":0},{"id":"2533650532","title":"Atea Pharmaceuticals, Inc.盘中异动 股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533650532","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533650532?lang=zh_cn&edition=full","pubTime":"2025-05-07 01:11","pubTimestamp":1746551493,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日01时11分,Atea Pharmaceuticals, Inc.股票出现异动,股价急速跳水5.07%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为5.64%。Atea Pharmaceuticals, Inc.公司简介:Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化抗病毒疗法,以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507011133a4744590&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507011133a4744590&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AVIR"],"gpt_icon":0},{"id":"2528749393","title":"Atea Pharmaceuticals, Inc.盘中异动 早盘快速拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528749393","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528749393?lang=zh_cn&edition=full","pubTime":"2025-04-17 22:11","pubTimestamp":1744899062,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日22时11分,Atea Pharmaceuticals, Inc.股票出现波动,股价急速拉升5.00%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.53%。Atea Pharmaceuticals, Inc.公司简介:Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化抗病毒疗法,以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041722110294d8dc3c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041722110294d8dc3c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVIR","BK4007"],"gpt_icon":0},{"id":"2528276364","title":"Atea Pharmaceuticals, Inc.盘中异动 大幅拉升5.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528276364","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528276364?lang=zh_cn&edition=full","pubTime":"2025-04-17 02:20","pubTimestamp":1744827645,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日02时20分,Atea Pharmaceuticals, Inc.股票出现波动,股价大幅上涨5.32%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为1.45%。Atea Pharmaceuticals, Inc.公司简介:Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化抗病毒疗法,以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417022045aa2c7212&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417022045aa2c7212&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVIR","BK4007"],"gpt_icon":0},{"id":"2527523198","title":"Atea Pharmaceuticals, Inc.盘中异动 急速拉升5.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527523198","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527523198?lang=zh_cn&edition=full","pubTime":"2025-04-14 22:05","pubTimestamp":1744639506,"startTime":"0","endTime":"0","summary":"北京时间2025年04月14日22时05分,Atea Pharmaceuticals, Inc.股票出现异动,股价大幅拉升5.72%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为1.51%。其相关个股中,Theratechnologies Inc.、Third Harmonic Bio, Inc.、Artelo Biosciences, Inc.涨幅较大,Artelo Biosciences, Inc.、Aditxt, Inc.、Processa Pharmaceuticals, Inc.较为活跃,换手率分别为510.40%、304.70%、143.66%,振幅较大的相关个股有Artelo Biosciences, Inc.、Theratechnologies Inc.、Metsera, Inc.,振幅分别为48.67%、29.90%、23.79%。Atea Pharmaceuticals, Inc.公司简介:Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化抗病毒疗法,以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414220506a6ba23bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414220506a6ba23bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AVIR"],"gpt_icon":0},{"id":"2518281053","title":"Atea Pharmaceuticals, Inc.2024财年实现净利润-1.68亿美元,同比减少23.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518281053","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518281053?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:01","pubTimestamp":1741536076,"startTime":"0","endTime":"0","summary":"3月10日,Atea Pharmaceuticals, Inc.公布财报,公告显示公司2024财年净利润为-1.68亿美元,同比减少23.53%;其中营业收入为0.00美元,每股基本收益为-2.00美元。机构评级:截至2025年3月10日,当前有1家机构对Atea Pharmaceuticals, Inc.目标价做出预测,其中目标均价为6.20美元,其中最低目标价为6.20美元,最高目标价为6.20美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000238a268987a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000238a268987a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVIR"],"gpt_icon":0},{"id":"1144965686","title":"Atea Pharmaceuticals公司第四季度每股亏损0.40美元,未达到预期的每股亏损0.37美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1144965686","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1144965686?lang=zh_cn&edition=full","pubTime":"2025-03-07 05:19","pubTimestamp":1741295973,"startTime":"0","endTime":"0","summary":"Atea Pharmaceuticals 公布的季度每股亏损为0.40美元,未达到分析师普遍预计的每股亏损0.37美元,差8.11%。相比去年同期的每股亏损0.47美元,这一亏损减少了14.89%。以上内容来自Benzinga Earnings专栏,原文如下:Atea Pharmaceuticals reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 8.11 percent. This is a 14.89 percent increase over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Atea Pharmaceuticals公司第四季度每股亏损0.40美元,未达到预期的每股亏损0.37美元","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVIR"],"gpt_icon":0},{"id":"2509253138","title":"Atea Pharmaceuticals, Inc.盘中异动 股价大涨5.05%报3.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509253138","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509253138?lang=zh_cn&edition=full","pubTime":"2025-02-06 03:31","pubTimestamp":1738783883,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日03时31分,Atea Pharmaceuticals, Inc.股票出现波动,股价快速拉升5.05%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为2.41%。其相关个股中,Invivyd, Inc.、Transcode Therapeutics, Inc.、Pasithea Therapeutics Corp.涨幅较大,Pasithea Therapeutics Corp.、Transcode Therapeutics, Inc.、Oragenics Inc.较为活跃,换手率分别为4636.38%、2352.41%、1754.62%,振幅较大的相关个股有Oragenics Inc.、Transcode Therapeutics, Inc.、Invivyd, Inc.,振幅分别为132.24%、99.51%、69.59%。Atea Pharmaceuticals, Inc.公司简介:Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化抗病毒疗法,以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206033124a23ab96d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206033124a23ab96d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AVIR"],"gpt_icon":0},{"id":"2500149497","title":"Atea Pharmaceuticals, Inc.盘中异动 大幅拉升5.12%报3.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500149497","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500149497?lang=zh_cn&edition=full","pubTime":"2025-01-04 01:03","pubTimestamp":1735923780,"startTime":"0","endTime":"0","summary":"北京时间2025年01月04日01时03分,Atea Pharmaceuticals, Inc.股票出现波动,股价急速上涨5.12%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.70%。Atea Pharmaceuticals, Inc.公司简介:Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化抗病毒疗法,以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250104010300985a55bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250104010300985a55bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVIR","BK4007"],"gpt_icon":0},{"id":"2500971389","title":"Atea Pharmaceuticals, Inc.盘中异动 早盘快速上涨5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500971389","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500971389?lang=zh_cn&edition=full","pubTime":"2025-01-03 00:14","pubTimestamp":1735834476,"startTime":"0","endTime":"0","summary":"北京时间2025年01月03日00时14分,Atea Pharmaceuticals, Inc.股票出现波动,股价大幅上涨5.37%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.79%。Atea Pharmaceuticals, Inc.公司简介:Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化抗病毒疗法,以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103001436985912f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103001436985912f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVIR","BK4007"],"gpt_icon":0},{"id":"2493426281","title":"Atea Pharmaceuticals, Inc.盘中异动 股价大涨5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493426281","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493426281?lang=zh_cn&edition=full","pubTime":"2024-12-21 00:50","pubTimestamp":1734713422,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日00时50分,Atea Pharmaceuticals, Inc.股票出现波动,股价快速拉升5.11%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中,整体涨幅为0.63%。Atea Pharmaceuticals, Inc.公司简介:Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化抗病毒疗法,以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221005022984cfe97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221005022984cfe97&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AVIR"],"gpt_icon":0},{"id":"2491692122","title":"Atea Pharmaceuticals, Inc.盘中异动 股价大涨9.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491692122","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491692122?lang=zh_cn&edition=full","pubTime":"2024-12-16 22:31","pubTimestamp":1734359486,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日22时31分,Atea Pharmaceuticals, Inc.股票出现异动,股价急速上涨9.22%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.02%。Atea Pharmaceuticals, Inc.公司简介:Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化抗病毒疗法,以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216223126a1f3428c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216223126a1f3428c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVIR","BK4007"],"gpt_icon":0},{"id":"2490042519","title":"Atea Pharmaceuticals, Inc.盘中异动 股价大跌5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490042519","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490042519?lang=zh_cn&edition=full","pubTime":"2024-12-11 02:25","pubTimestamp":1733855133,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日02时25分,Atea Pharmaceuticals, Inc.股票出现波动,股价大幅下跌5.30%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.92%。Atea Pharmaceuticals, Inc.公司简介:Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化抗病毒疗法,以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211022533a1e3fb75&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211022533a1e3fb75&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVIR","BK4007"],"gpt_icon":0},{"id":"2489468852","title":"Atea Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.14%报2.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489468852","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489468852?lang=zh_cn&edition=full","pubTime":"2024-12-05 22:38","pubTimestamp":1733409511,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日22时38分,Atea Pharmaceuticals, Inc.股票出现波动,股价急速下跌5.14%。截至发稿,该股报2.96美元/股,成交量2.6289万股,换手率0.03%,振幅4.82%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.01%。Atea Pharmaceuticals, Inc.公司简介:Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化抗病毒疗法,以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205223831a1d69d5f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205223831a1d69d5f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVIR","BK4007"],"gpt_icon":0},{"id":"2488190863","title":"Atea Pharmaceuticals, Inc.盘中异动 早盘急速下跌5.17%报3.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488190863","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488190863?lang=zh_cn&edition=full","pubTime":"2024-12-04 22:57","pubTimestamp":1733324277,"startTime":"0","endTime":"0","summary":"北京时间2024年12月04日22时57分,Atea Pharmaceuticals, Inc.股票出现波动,股价大幅跳水5.17%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中,整体跌幅为0.04%。Atea Pharmaceuticals, Inc.公司简介:Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司,专注于发现、开发和商业化抗病毒疗法,以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204225757971ba1f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241204225757971ba1f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVIR","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ateapharma.com","stockEarnings":[{"period":"1week","weight":0.0107},{"period":"1month","weight":0.1739},{"period":"3month","weight":0.3948},{"period":"6month","weight":0.156},{"period":"1year","weight":0.1924},{"period":"ytd","weight":0.1284}],"compareEarnings":[{"period":"1week","weight":0.0008},{"period":"1month","weight":0.0377},{"period":"3month","weight":0.1721},{"period":"6month","weight":0.0781},{"period":"1year","weight":0.1149},{"period":"ytd","weight":0.0678}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Atea Pharmaceuticals, Inc.于2012年7月注册成立,并于2014年3月开始主要运营。该公司是一家临床阶段的生物制药公司,利用对抗病毒药物开发、药物化学、生物学、生物化学和病毒学的深刻理解,发现和开发新型口服候选产品,以治疗严重的病毒性疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.15717},{"month":2,"riseRate":0.4,"avgChangeRate":-0.057777},{"month":3,"riseRate":0.2,"avgChangeRate":-0.034263},{"month":4,"riseRate":0,"avgChangeRate":-0.181647},{"month":5,"riseRate":0.6,"avgChangeRate":0.077532},{"month":6,"riseRate":0.4,"avgChangeRate":0.000859},{"month":7,"riseRate":0.8,"avgChangeRate":0.088371},{"month":8,"riseRate":0.5,"avgChangeRate":0.022245},{"month":9,"riseRate":0.25,"avgChangeRate":-0.074667},{"month":10,"riseRate":0.5,"avgChangeRate":-0.140755},{"month":11,"riseRate":0.4,"avgChangeRate":-0.089908},{"month":12,"riseRate":0.8,"avgChangeRate":0.076831}],"exchange":"NASDAQ","name":"Atea Pharmaceuticals, Inc.","nameEN":"Atea Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Atea Pharmaceuticals, Inc.(AVIR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Atea Pharmaceuticals, Inc.(AVIR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Atea Pharmaceuticals, Inc.,AVIR,Atea Pharmaceuticals, Inc.股票,Atea Pharmaceuticals, Inc.股票老虎,Atea Pharmaceuticals, Inc.股票老虎国际,Atea Pharmaceuticals, Inc.行情,Atea Pharmaceuticals, Inc.股票行情,Atea Pharmaceuticals, Inc.股价,Atea Pharmaceuticals, Inc.股市,Atea Pharmaceuticals, Inc.股票价格,Atea Pharmaceuticals, Inc.股票交易,Atea Pharmaceuticals, Inc.股票购买,Atea Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Atea Pharmaceuticals, Inc.(AVIR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Atea Pharmaceuticals, Inc.(AVIR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}